Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust
This paper examines one nascent entrepreneurial endeavour intended by Canada’s Stem Cell Network to catalyze the commercialization of stem cell research: the creation of a company called “Aggregate Therapeutics”. We argue that this initiative, in its current configuration, is likely to result in a b...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Springer
2008
|
| In: |
Journal of business ethics
Year: 2008, Volume: 77, Issue: 1, Pages: 73-84 |
| Further subjects: | B
Patents
B Canada B Biotechnology B stem cell B Intellectual Property B commercialization B Public Trust B Governance |
| Online Access: |
Volltext (JSTOR) Volltext (lizenzpflichtig) |